Doxorubicin‐associated takotsubo cardiomyopathy in a patient with adult T‐cell leukemia/lymphoma

This case highlights the first reported association of doxorubicin with takotsubo cardiomyopathy (TC) presenting as cardiogenic shock during the first continuous infusion in a patient with adult T‐cell leukemia/lymphoma. We aim to raise awareness to recognize and distinguish between irreversible doxorubicin‐associated cardiomyopathy and reversible doxorubicin‐associated TC in patients with cancer.